|

Mocertatug rezetecan Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 3: 2

Top Sponsors

  • GlaxoSmithKline3

Indications

  • Cancer3
  • Neoplasms, Endometrial1
  • Ovarian Neoplasms1
  • Solid Tumors1
  • Neoplasms1

Other2 trials

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Phase 3
A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
Phase 3

Birmingham, Alabama1 trial

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

GSK Investigational Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.